Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases

被引：0
作者：
Fan, Y. [1 ]
Yu, X. [2 ]
Wang, H. [2 ]
机构：
[1] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Epidermal growth factor receptor; Tyrosine kinase inhibitors; brain metastases;
D O I：
10.1016/j.jtho.2017.09.1510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-069
引用
收藏
页码：S2228 / S2228
页数：1
相关论文
共 50 条
[21]   EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors? [J].
Cansouline, Xavier ;
Lipan, Beatrice ;
Sizaret, Damien ;
Tallet, Anne ;
Vandier, Christophe ;
Carmier, Delphine ;
Legras, Antoine .
CANCERS, 2022, 14 (09)
[22]   The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer [J].
Bai, Hao ;
Xiong, Liwen ;
Han, Baohui .
ONCOTARGETS AND THERAPY, 2017, 10 :2335-2340
[23]   Non-Small-Cell Lung Cancer and Brain Metastases in Brazil [J].
Weis, Luiza N. ;
Coelho, Juliano C. ;
Marks, Patricia ;
Geib, Guilherme ;
Liedke, Pedro ;
Pereira, Rodrigo ;
Schwartsmann, Gilberto ;
Azevedo, Sergio .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) :S204-S205
[24]   Management of EGFR-Mutant Non-Small Cell Lung Cancer: Focus on Gefitinib [J].
Naito, Yoichi ;
Goto, Koichi .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 :1027-1040
[25]   The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases [J].
Van Pham, Thai ;
Vu, Thanh Ha ;
Nguyen, Hoa Thai Thi ;
Pham, Phuong Cam ;
Do, Anh Tu ;
Nguyen, Tuan Khoi ;
Hoang, Thi Anh Thu ;
Le, Tuan Anh ;
Vuong, Dinh Thy Hao ;
Nguyen, Dac Nhan Tam ;
Dang, Van Khiem ;
Nguyen, Thi Oanh ;
Pham, Van Luan ;
Nguyen, Minh Hai ;
Vo, Thi Huyen Trang ;
Mai, Khoa Trong ;
Do, Hung Kien ;
Nguyen, Thi Thuy Hang ;
Trinh, Le Huy ;
Nguyen, Hoang Gia ;
Truong, Cong Minh ;
Pham, Tran Minh Chau .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025, 21 (03) :281-289
[26]   Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study) [J].
Okuma, Yusuke ;
Nomura, Shogo ;
Ninomiya, Kiichiro ;
Gyotoku, Hiroshi ;
Murakami, Shuji ;
Kogure, Yoshihito ;
Harada, Daijiro ;
Okishio, Kyoichi ;
Okamoto, Hiroaki ;
Goto, Yasushi .
FUTURE ONCOLOGY, 2023, :1515-1521
[27]   Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis [J].
Yoshimura, Akihiro ;
Yamada, Tadaaki ;
Tsuji, Taisuke ;
Hamashima, Ryosuke ;
Shiotsu, Shinsuke ;
Yuba, Tatsuya ;
Takumi, Chieko ;
Uchino, Junji ;
Hiraoka, Noriya ;
Takayama, Koichi .
THORACIC CANCER, 2019, 10 (03) :557-563
[28]   EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data [J].
Fan, Yun ;
Xu, Xiaoling ;
Xie, Conghua .
ONCOTARGETS AND THERAPY, 2014, 7 :2075-2084
[29]   Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis [J].
He, Mingfeng ;
Wu, Xue ;
Li, Li ;
Yi, Guangming ;
Wang, Yitian ;
He, Hengqiu ;
Ye, Ying ;
Zhou, Ruiqin ;
Xu, Zaicheng ;
Yang, Zhenzhou .
RADIATION ONCOLOGY, 2025, 20 (01)
[30]   Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer [J].
Baik, Christina S. ;
Chamberlain, Marc C. ;
Chow, Laura Q. .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :1268-1278
12345